Company / Operating Cash Flow per Share
4D Molecular Therapeutics, Inc. Operating Cash Flow per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$2.94
FY2025
5-year range
-$2.94 / -$1.76
FY2021-FY2025
Trend
-67.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share has fluctuated over the past 6 years, ranging from $-7.09 in FY2020 to $-1.76 in FY2024.
Based on SEC 10-K filings.
-2.94 in FY2025.
Declined from $-2.66 to $-2.94 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow per share decreased 67.0% year-over-year.
- Peak operating cash flow per share was recorded in FY2024.
- Lowest operating cash flow per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.26 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.94 | -67.0% |
| FY2024 | -$1.76 | +33.8% |
| FY2023 | -$2.66 | -23.8% |
| FY2022 | -$2.15 | -12.4% |
| FY2021 | -$1.91 | +73.1% |
| FY2020 | -$7.09 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026